Contracts & Grants
Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.
New
Catherine Ambrose, Medical School (MS), Biomechanical Evaluation of Anatomic Contoured Locking Plates for Periarticular Fractures, Zimmer, $80,947.
Ben Barnett, MS, A Randomized, Controlled, Open-Label Trial to Compare the Efficacy, Safety and Tolerability of TMC 114/RTV Versus LPV/RTV in Treatment Experienced HIV-1 Infected Subjects, PPD Development, LP, $74,100.
Eric Boerwinkle, School of Public Health (SPH), Graduate School of Biomedical Sciences (GSBS) and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), Pharmacogenomic Evaluation of Antihypertensive Responses, University of Florida, $86,595; and GENHAT-Genetics of Hypertension Associated Treatment, University of Alabama at Birmingham, $347,367.
Guy Clifton, MS, Anterior Cervical Fusion Outcomes Study, Aesculap Inc., USA, $62,782.
Barry Davis, SPH, GENHAT-Genetics of Hypertension Associated Treatments, University of Alabama at Birmingham, $214,818.
Anne Dougherty, MS, Advancements in ICD Therapy (ACT) Registry, St. Jude Medical Inc., $384,000.
Danielle Garsin, MS and GSBS, Genomic Comparison of Infectious Strains of E. Faecalis, Baylor College of Medicine, $14,546.
Raymond Grill, MS and GSBS, Glial Activation in Spinal Cord Injury-Induced Neuropathic Pain, The Institute for Rehabilitation and Research, $43,500.
Adelaide Hebert, MS, Novel Treatment for Disorders of Keratinzation, Biomedical Development Corporation, $12,692.
Jacqueline Hecht, MS and GSBS, Mortality in Achondroplasia Study, Smart Family Foundation, $5,000.
Gloria Heresi, MS, Longitudinal Epidemiologic Study to Gain Insight into HIV and AIDS in Children and Youth (LEGACY),Westat Inc., $29,440.
Keith Hoots, MS and GSBS, A Randomized Two-Way Blinded Crossover-Design Study to Establish the Bioequivalence of B-Domain Deleted Recombinant Factor VIII (BDDRFVIII, Refacto AF) with a Full- Length Recombinant Factor VIII Preparation (FLRFVIII, Advate), Followed by an Open-Label Trial, Wyeth Pharmaceuticals, $41,327.
Barbara Murray, MS and GSBS, Genomic Comparison of Infectious Strains E. Faecalis, Baylor College of Medicine, $20,054.
Paula O’Neill, Dental Branch (DB), Summer Medical and Dental Education Program: Health Education Academic Training (H.E.A.T.) Initiative, Robert Wood Johnson Foundation, $1,181,239.
John Powers, DB and GSBS, Properties of SENN, GC America Inc., $9,000.
Marek Radomski, IMM, Effects of Novel Formulations of Non- Steroidal Anti-Inflammatory Drugs on Platelet Aggregation, PLX Pharma Inc., $56,550.
Richard Smalling, MS, Phase III, International Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition with Tilarginine Acetate Injection in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction (TRIUMPH), Arginox Pharmaceuticals Inc., $70,590.
James Turley, School of Health Information Sciences, Medication Administration Error Prevention System, Software Techniques Inc., $37,005.
Deepa Vasudevan, MS, Prevalence and Predictors of Weight Gain at One Year Postpartum, Texas Academy of Family Physicians Foundation, $4,979.
Jack Waymire, MS and GSBS, 14-3-3-Protein’s Role in Dopamine Biosynthesis Regulation, LSU Research Foundation, $4,000.
Renewal
Hope Northrup, MS and GSBS, Comprehensive Metropolitan and Outreach Genetic Services, Texas Department of State Health Services, $195,298.